Search Results - "Ocak, Meltem"
-
1
Application of response surface methodology and quality by design to [68Ga]Ga-PSMA-11 preparation
Published in Journal of radioanalytical and nuclear chemistry (2024)“…In this study, the optimum conditions for the synthesis of [ 68 Ga]Ga-PSMA-11 were determined for the first time using the Quality by Design (QbD). The…”
Get full text
Journal Article -
2
EANM guideline on the validation of analytical methods for radiopharmaceuticals
Published in EJNMMI radiopharmacy and chemistry (12-02-2020)“…Background To fulfil good manufacturing requirements, analytical methods for the analysis of pharmaceuticals for human and vetinary use must be validated. The…”
Get full text
Journal Article -
3
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
Published in EJNMMI radiopharmacy and chemistry (12-02-2021)“…This guideline on current good radiopharmacy practice (cGRPP) for small-scale preparation of radiopharmaceuticals represents the view of the Radiopharmacy…”
Get full text
Journal Article -
4
Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT
Published in Annals of nuclear medicine (01-08-2021)“…Objective PET imaging with F-18 DOPA (FDOPA) and Ga-68 DOTATATE (TATE) shows the most promising results to detect medullary thyroid cancer (MTC) recurrence. We…”
Get full text
Journal Article -
5
[68Ga]DOTA-FAPI-04 PET/CT imaging in a case of a signet ring cell carcinoma of stomach
Published in European journal of nuclear medicine and molecular imaging (01-12-2021)Get full text
Journal Article -
6
Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging
Published in Korean journal of radiology (01-02-2020)“…Our aim was to assess the diagnostic performance of F-18 fluorocholine (FCH) positron emission tomography/computed tomography (PET/CT) in detecting…”
Get full text
Journal Article -
7
Folate Receptor-Targeted Multimodality Imaging of Ovarian Cancer in a Novel Syngeneic Mouse Model
Published in Molecular pharmaceutics (02-02-2015)“…A new transplantable ovarian tumor model is presented using a novel folate receptor (FR) positive, murine ovarian cancer cell line that emulates the human…”
Get full text
Journal Article -
8
Preclinical Evaluation of F-ML-10 to Determine Timing of Apoptotic Response to Chemotherapy in Solid Tumors
Published in Molecular imaging (01-01-2017)“…Purpose: We investigated 2-(5-fluoro-pentyl)-2-methyl-malonic acid ( 18 F-ML-10) positron emission tomography (PET) imaging of apoptosis posttherapy to…”
Get full text
Journal Article -
9
Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry
Published in Molecular imaging and radionuclide therapy (01-06-2017)“…The aim of the study was to estimate the radiation-absorbed doses and to study the in vivo and in vitro stability as well as pharmacokinetic characteristics of…”
Get full text
Journal Article -
10
Radiolabelling of peptides for PET, SPECT and therapeutic applications using a fully automated disposable cassette system
Published in Nuclear medicine communications (01-10-2011)“…OBJECTIVESRadiolabelled somatostatin analogues have found wide clinical use in nuclear medicine for both diagnostic and therapeutic applications. Here, we…”
Get full text
Journal Article -
11
Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer
Published in European journal of nuclear medicine and molecular imaging (01-12-2015)“…(177)Lu-617-prostate-specific membrane antigen (PSMA) ligand seems to be a promising tracer for radionuclide therapy of progressive prostate cancer. However,…”
Get full text
Journal Article -
12
(68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma
Published in European journal of nuclear medicine and molecular imaging (01-07-2014)Get full text
Journal Article -
13
Post-therapy imaging of 225Ac-DOTATATE treatment in a patient with recurrent neuroendocrine tumor
Published in European journal of nuclear medicine and molecular imaging (01-10-2020)Get full text
Journal Article -
14
Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours
Published in European journal of nuclear medicine and molecular imaging (01-08-2012)“…Purpose Recent studies have suggested that positron emission tomography (PET) imaging with 68 Ga-labelled DOTA-somatostatin analogues (SST) like octreotide and…”
Get full text
Journal Article -
15
Clinical Experience with [ 225 Ac]Ac-PSMA Treatment in Patients with [ 177 Lu]Lu-PSMA–Refractory Metastatic Castration-Resistant Prostate Cancer
Published in Journal of Nuclear Medicine (01-10-2023)“…For patients with advanced-stage metastatic castration-resistant prostate cancer (mCRPC) who do not respond to [177Lu]Lu-PSMA therapy, there are limited…”
Get full text
Journal Article -
16
Development and validation of a UV-Radio-HPLC method to assess chemical and radiochemical purity of [68Ga] Ga-PSMA-11
Published in Applied radiation and isotopes (01-12-2022)“…[68Ga]Ga-PSMA-11, a urea-based peptidomimetic, has been widely used in recent years for PET imaging of patients with prostate cancer. Since it has short…”
Get full text
Journal Article -
17
Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria
Published in Nuclear medicine communications (01-08-2020)“…AIMIn this study, we aimed to measure interobserver and intraobserver agreement in Ga-68–prostate-specific membrane antigen (PSMA) PET/computed tomography (CT)…”
Get full text
Journal Article -
18
EANM guideline on quality risk management for radiopharmaceuticals
Published in European journal of nuclear medicine and molecular imaging (01-08-2022)“…This document is intended as a supplement to the EANM “Guidelines on current Good Radiopharmacy Practice (cGRPP)” issued by the Radiopharmacy Committee of the…”
Get full text
Journal Article -
19
The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels
Published in Nuclear medicine communications (01-02-2017)“…INTRODUCTIONProstate-specific membrane antigen (PSMA) is increasingly being recognized as a novel target for the PET imaging of prostate cancer (PCa) and…”
Get full text
Journal Article -
20
Post-therapy imaging of 225 Ac-DOTATATE treatment in a patient with recurrent neuroendocrine tumor
Published in European journal of nuclear medicine and molecular imaging (01-10-2020)Get full text
Journal Article